Case |
Age In years |
Presentation |
ferritin |
BM biopsy |
BAL |
Other significant laboratory tests |
Diagnosis |
Treatment |
Outcome |
Karakosta et al., 2021 [8] |
68 |
Fever and respirator distress |
4062 ng/ml then increased to 23,863 ng/ml |
histiocytosis |
Revealed Aspergillus flavus |
Elevated Triglycerides and pancytopenia |
Acquired Hemophagocytic lymphohistiocytosis secondary to invasive pulmonary aspergillosis and Turicella Otitidis bacteremia |
Broad spectrum antibiotics, Itraconazole and IV Hydrocortisone |
death |
Schouten MJG et al., 2017 [9] |
38 |
Respiratory failure and fever |
2961 ng/ml |
Not done |
positive for influenza-A and aspergillus fumigatus |
Low NK activity |
HLH secondary to influenza and invasive pulmonary aspergillosis |
-Anakinra (interleukin-1 receptor antagonist), Antiviral (oseltamivir), Antifungal (amphotericin-B and voriconazole) and Interferon-gamma |
death |
Umekawa et al., 2020 [10] |
54 |
Fever, dyspnea and skin rash |
14.790 ng/ml |
not done |
Revealed Aspergillus fumigatus |
ANA 1:80, elevated CD25 3,970 pg/ml and Decreased NK cell activity |
Secondary Hemophagocytic Lymphohistiocytosis Associated with Invasive pulmonary Aspergillosis and the patient was eventually diagnosed with dermatomyositis |
IVIG and antifungal therapy |
Improved then the patient developed recurrence of secondary HLH associated with disseminated tuberculosis |
Paul M, et al., 2022 [11] |
68 |
Fever, Acute respiratory distress and Impaired consciousness |
141,918 ng/ml |
hemophagocytosis |
BAL was not done, the patient had positive serum galactomannan |
Elevated triglycerides |
HLH secondary to mucormycosis and aspergillosis coinfection |
Etoposide, steroid therapy, Tocilizumab and Antifungal therapy |
death |
Gandotra A, et al., 2022 [12] |
47 |
Fever and respiratory distress in a liver transplant recipient who was recovering from severe COVID-19 infection |
27,717 ng/ml |
hemophagocytosis |
Not done |
Sputum culture was positive for acid fast bacilli and sputum fungal culture was positive for Aspergillus Flavus |
Invasive pulmonary Aspergillosis and Tuberculosis complicated by HLH in sequelae of COVID-19 in a liver transplant recipient |
IVIG, Antitubercular therapy and Antifungal therapy |
recovered |
Bello, A et al., 2018 [13] |
9 |
Fever with respiratory distress |
14,000 ng/ml |
Not done |
Not done |
Elevated triglycerides |
Aspergillus induced HLH in child with acute lymphoblastic leukemia |
Antifungal therapy |
recovered |